Medicament and Diagnosis for Spink1 Positive Cancer
Non-Confidential description of the invention
The invention is in the field of therapeutic medication for the treatment of cancer, preferably SPINK1 associated cancers. It also provides Biomarkers for Cancer and particularly detecting SPINK1-positive vs. SPINK1-negative subtype of cancers. The invention is also effective in SPINK1- positive cancer patients responding to the microRNA replacement therapy.
Dr.Bushra Ateeq(BSBE), Mr.Vipul Bhatia(PhD Student,BSBE), Ms.Anjali Yadav(PhD Student,BSBE)
Date of Filing